An interventional study of Ondansetron in Sedation and Analgesia and Side Effect of Drug, sponsored by Seoul National University Hospital. Status unknown at 1 site in Korea, Republic of. Open to participants aged 3 Months and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2012-01-20.
Sponsored by Seoul National University Hospital · Not applicable, Interventional, and Treatment
The purpose of this study is to evaluate the anti-emetic effect of oral ondansetron. For this evaluation, the investigators will perform a multi-center, double-blind, placebo-controled, randomized study. The investigators assumption is that oral ondansetron prior to intramuscular ketamine will reduce the occurrence of ketamine-induced vomiting.
Methods
Primary outcome
Secondary outcome
437 studies on the registry are indexed under Drug-Related Side Effects and Adverse Reactions; 76 are open to participants now.
This study's planned enrollment of 266 is above the median of 103 across 255 interventional studies indexed under Drug-Related Side Effects and Adverse Reactions.
Browse Drug-Related Side Effects and Adverse Reactions studies →Seoul National University Hospital is the lead sponsor of 1,860 studies on the registry; 275 are open to participants now.
Of its 12 completed or terminated interventional studies of FDA-regulated products, 2 (17%) have results posted.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Ondansetron use group
Drug: Ondansetron
Placebo group
Drug: Ondansetron
2mg (5mL) in \< 15 kg and 4mg (10mL) in 15kg to 30kg
Also known as: Zofran zydis, vomiset
vomiting at ED stay and 12 hours after discharge
Time frame: the participants will be followed for the duration of ED stay (upto 24hr) and 12hours after discharge
parent's satisfaction
Time frame: satisfaction will be surveyed within 48hours after discharge
length of emergency department stay
Time frame: length of stay will be calculated upto 24 hours
This study is status unknown, as verified in Jan 2012. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Drug-Related Side Effects and Adverse Reactions→
Seoul National University Hospital